Hudson Edge Investment Partners Inc. Decreases Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Hudson Edge Investment Partners Inc. cut its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 38.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 40,749 shares of the company’s stock after selling 25,023 shares during the quarter. Hudson Edge Investment Partners Inc.’s holdings in Henry Schein were worth $2,820,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also bought and sold shares of HSIC. Clarkston Capital Partners LLC increased its position in Henry Schein by 5.4% during the 3rd quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after purchasing an additional 71,560 shares during the period. Nuance Investments LLC boosted its stake in shares of Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares in the last quarter. Olstein Capital Management L.P. increased its position in shares of Henry Schein by 17.2% during the fourth quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after buying an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new position in Henry Schein in the third quarter worth about $515,000. Finally, Equitable Trust Co. purchased a new stake in Henry Schein in the fourth quarter worth about $417,000. 96.62% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on HSIC shares. Barrington Research upped their price target on Henry Schein from $82.00 to $90.00 and gave the stock an “outperform” rating in a research note on Thursday, January 30th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. Jefferies Financial Group boosted their price objective on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Finally, Wells Fargo & Company started coverage on shares of Henry Schein in a research note on Friday, February 14th. They set an “equal weight” rating and a $80.00 target price for the company. Eight research analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $80.09.

Henry Schein Trading Down 1.0 %

Henry Schein stock opened at $77.24 on Friday. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The company has a market cap of $9.63 billion, a P/E ratio of 31.79, a P/E/G ratio of 2.12 and a beta of 0.91. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The business has a 50-day simple moving average of $74.14 and a two-hundred day simple moving average of $72.21.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.